GOLDMAN SACHS GROUP INC - REVIVA PHARMACEUTCLS HLDGS I ownership

REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 26 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q2 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of REVIVA PHARMACEUTCLS HLDGS I
ValueSharesWeighting
Q1 2023$51,269
-58.7%
12,236
-58.1%
0.00%
Q4 2022$124,19429,2220.00%
Other shareholders
REVIVA PHARMACEUTCLS HLDGS I shareholders Q2 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,200,000$2,952,0000.59%
EMC Capital Management 55,078$135,0000.10%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Renaissance Technologies 12,700$31,0000.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 9,299$23,0000.00%
WELLS FARGO & COMPANY/MN 102$00.00%
GEODE CAPITAL MANAGEMENT, LLC 78,075$192,0000.00%
BANK OF AMERICA CORP /DE/ 2$00.00%
RAYMOND JAMES & ASSOCIATES 14,000$34,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 659$1,0000.00%
View complete list of REVIVA PHARMACEUTCLS HLDGS I shareholders